tripod-glp

tripod-glp resolves to TriApex Laboratories, a next-generation pharmaceutical and biomedical contract research organization (CRO) headquartered in Nanjing, China with facilities in Shanghai, Kunming, Wenchang and Pennsylvania. TriApex provides integrated nonclinical services (safety assessment, efficacy, DMPK and research models) and clinical trial services across phases I-III, with disease expertise spanning cardiometabolic, CNS, ophthalmology, autoimmune and oncology. Surfaced as a portfolio company of Qiming Venture Partners and added to the API Evangelist network, it publishes a corporate website (www.tri-apex.com) but no public API, developer portal, or documentation surface at this time.

tripod-glp is profiled on the APIs.io network. Tagged areas include Company, Contract Research Organization, Pharmaceutical, Biomedical Research, and Clinical Trials.

7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyContract Research OrganizationPharmaceuticalBiomedical ResearchClinical TrialsPreclinicalLife SciencesHealthcare

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/tripod-glp: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Tripod Glp Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Company 1

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: tripod-glp
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/tripod-glp.png
name: tripod-glp
description: tripod-glp resolves to TriApex Laboratories, a next-generation pharmaceutical and biomedical contract research
  organization (CRO) headquartered in Nanjing, China with facilities in Shanghai, Kunming, Wenchang and Pennsylvania. TriApex
  provides integrated nonclinical services (safety assessment, efficacy, DMPK and research models) and clinical trial services
  across phases I-III, with disease expertise spanning cardiometabolic, CNS, ophthalmology, autoimmune and oncology. Surfaced
  as a portfolio company of Qiming Venture Partners and added to the API Evangelist network, it publishes a corporate website
  (www.tri-apex.com) but no public API, developer portal, or documentation surface at this time.
url: https://raw.githubusercontent.com/api-evangelist/tripod-glp/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Contract Research Organization
- Pharmaceutical
- Biomedical Research
- Clinical Trials
- Preclinical
- Life Sciences
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/tripod-glp-domain-security.yml
- type: Website
  url: https://www.tri-apex.com
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1